Abstract
Analysis of covariance was employed to explore possible correlations among duration of phenytoin therapy, phenytoin and folate serum concentrations, and clinical and electrophysiologic findings in 32 patients receiving single phenytoin therapy. None of our patients volunteered peripheral nervous system complaints. On examination, 9 of 32 (28%) were found to have signs suggestive of neuropathy (absent knee and/or ankle jerks). Neither phenytoin serum concentration nor duration of phenytoin therapy was found to significantly (p greater than 0.05) affect nerve function after an adjustment for age differences. A test for overall effect of folate serum concentration (grouped greater than or equal to 5 or less than 5 ng/ml) also failed to reach statistical significance (p greater than 0.05). Our findings suggest that phenytoin and folate serum concentrations and duration of phenytoin therapy do not have an important role in the development of clinical neuropathy and electrophysiologic abnormalities.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
